Gilead Sciences

Gilead ramps up production of experimental Covid-19 treatment amid criticism over access
Gilead ramps up production of experimental Covid-19 treatment amid criticism over access
Stat
Gilead Sciences
COVID-19
remdesivir
drug manufacturing
Flag link:
EMA Recommends Remdesivir for Treatment of COVID-19 Under Compassionate-Use Rules
EMA Recommends Remdesivir for Treatment of COVID-19 Under Compassionate-Use Rules
Motley Fool
Gilead Sciences
Europe
COVID-19
remdesivir
Flag link:
A Covid-19 threat to business acquisitions
A Covid-19 threat to business acquisitions
EP Vantage
COVID-19
M&A
AbbVie
Allergan
Arya Sciences
Immatics
AcelRx
Tetraphase
Gilead Sciences
Forty Seven
Thermo Fisher
Stryker
Wright Medical
Flag link:
Motion denied: Gilead still on the hook for $1.5B in damages over CAR-T patent dispute with Bristol Myers Squibb
Motion denied: Gilead still on the hook for $1.5B in damages over CAR-T patent dispute with Bristol Myers Squibb
Endpoints
Gilead Sciences
CAR-T
Bristol-Meyers Squibb
Juno Therapeutics
patents
Flag link:
Gilead Sciences Expects Coronavirus Drug Data in Coming Weeks, Expands Access
Gilead Sciences Expects Coronavirus Drug Data in Coming Weeks, Expands Access
Yahoo/SmarterAnalyst
Gilead Sciences
remdesivir
COVID-19
Flag link:
WHO Initiates a Clinical Trial for Four Drugs in Fight Against COVID-19
WHO Initiates a Clinical Trial for Four Drugs in Fight Against COVID-19
BioSpace
WHO
Norway
Spain
clinical trials
COVID-19
hydroxychloroquine
Gilead Sciences
remdesivir
Lopinavir
ritonavir
Flag link:
For Gilead, Its Coronavirus Treatment Is Icing on the Cake
For Gilead, Its Coronavirus Treatment Is Icing on the Cake
Motley Fool
Gilead Sciences
remdesivir
COVID-19
KTE-X19
magrolimab
Flag link:
Pharma giants including Novartis collaborate on COVID-19 therapies
Pharma giants including Novartis collaborate on COVID-19 therapies
Pharmaforum
JNJ
Novartis
Boehringer Ingelheim
Biomerieux
Eisai
Eli Lilly
Gilead Sciences
GSK
Merck
Merck KGaA
Pfizer
Sanofi
R&D
COVID-19
diagnostics
vaccines
Flag link:
Gilead Asks the FDA to Rescind Orphan Drug Designation for Remdesivir as a Treatment for COVID-19
Gilead Asks the FDA to Rescind Orphan Drug Designation for Remdesivir as a Treatment for COVID-19
Motley Fool
Gilead Sciences
remdesivir
FDA
orphan drugs
COVID-19
Flag link:
Galapagos CEO talks next steps as coronavirus stalls the biotech's top drug
Galapagos CEO talks next steps as coronavirus stalls the biotech's top drug
BioPharma Dive
Galapagos
Gilead Sciences
filgotinib
rheumatoid arthritis
FDA
COVID-19
Flag link:
When might experimental drugs to treat Covid-19 be ready? A forecast
When might experimental drugs to treat Covid-19 be ready? A forecast
Stat
COVID-19
coronaviruses
drug development
remdesivir
Gilead Sciences
vaccines
antibodies
Flag link:
Gilead pauses access to experimental Covid-19 drug due to ‘overwhelming demand’
Gilead pauses access to experimental Covid-19 drug due to ‘overwhelming demand’
Stat
Gilead Sciences
remdesivir
COVID-19
Flag link:
All the Drugs Proving Anecdotally Effective Against COVID-19, and the Companies That Make Them
All the Drugs Proving Anecdotally Effective Against COVID-19, and the Companies That Make Them
Motley Fool
COVID-19
Gilead Sciences
Mylan
Bayer
chloroquine
hydroxychloroquine
Fujifilm
Avigan
Kevzara
Actemra
Regeneron
Sanofi
Roche
Flag link:
FDA Approves Gilead’s Epclusa for Children with Hepatitis C
FDA Approves Gilead’s Epclusa for Children with Hepatitis C
BioSpace
Epclusa
hepatitis C
Gilead Sciences
FDA
pediatric
Flag link:
FDA chief highlights Gilead drug’s availability under compassionate use for Covid-19
FDA chief highlights Gilead drug’s availability under compassionate use for Covid-19
MedCity News
FDA
Stephen Hahn
remdesivir
compassionate use guidelines
Gilead Sciences
COVID-19
Flag link:
Can This American Biotech Company Save the Global Economy?
Can This American Biotech Company Save the Global Economy?
Motley Fool
Gilead Sciences
remdesivir
COVID-19
biotech
coronaviruses
Flag link:
Early Results Dampen Outlook for Experimental COVID-19 Treatment
Early Results Dampen Outlook for Experimental COVID-19 Treatment
Motley Fool
Gilead Sciences
remdesivir
COVID-19
coronaviruses
Flag link:
A new paper about a Gilead drug to combat coronavirus has some analysts skittish about success
A new paper about a Gilead drug to combat coronavirus has some analysts skittish about success
Stat
Gilead Sciences
remdesivir
COVID-19
coronaviruses
Flag link:
How Gilead's blood cancer med Zydelig might also address triple-negative breast cancer
How Gilead's blood cancer med Zydelig might also address triple-negative breast cancer
Fierce Biotech
Gilead Sciences
Zydelig
breast cancer
triple negative breast cancer
Flag link:
CDC: Gilead Sciences' Remdesivir Is Being Used to Treat Coronavirus Patients
CDC: Gilead Sciences' Remdesivir Is Being Used to Treat Coronavirus Patients
Motley Fool
Gilead Sciences
CDC
remdesivir
COVID-19
coronaviruses
Flag link:

Pages